Literature DB >> 22982684

Comparative gene expression profiling in human-induced pluripotent stem cell--derived cardiocytes and human and cynomolgus heart tissue.

Dinesh Puppala1, Leon P Collis, Sunny Z Sun, Vinicius Bonato, Xian Chen, Blake Anson, Mathew Pletcher, Bernard Fermini, Sandra J Engle.   

Abstract

Cardiotoxicity is one of the leading causes of drug attrition. Current in vitro models insufficiently predict cardiotoxicity, and there is a need for alternative physiologically relevant models. Here we describe the gene expression profile of human-induced pluripotent stem cell-derived cardiocytes (iCC) postthaw over a period of 42 days in culture and compare this profile to human fetal and adult as well as adult cynomolgus nonhuman primate (NHP, Macaca fascicularis) heart tissue. Our results indicate that iCC express relevant cardiac markers such as ion channels (SCN5A, KCNJ2, CACNA1C, KCNQ1, and KCNH2), tissue-specific structural markers (MYH6, MYLPF, MYBPC3, DES, TNNT2, and TNNI3), and transcription factors (NKX2.5, GATA4, and GATA6) and lack the expression of stem cell markers (FOXD3, GBX2, NANOG, POU5F1, SOX2, and ZFP42). Furthermore, we performed a functional evaluation of contractility of the iCC and showed functional and pharmacological correlations with myocytes isolated from adult NHP hearts. These results suggest that stem cell-derived cardiocytes may represent a novel in vitro model to study human cardiac toxicity with potential ex vivo and in vivo translation.

Entities:  

Mesh:

Year:  2012        PMID: 22982684     DOI: 10.1093/toxsci/kfs282

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  15 in total

1.  Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways.

Authors:  Liang Guo; Sandy Eldridge; Mike Furniss; Jodie Mussio; Myrtle Davis
Journal:  Curr Protoc Chem Biol       Date:  2015-09-01

Review 2.  Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?

Authors:  Tarek Magdy; Brian T Burmeister; Paul W Burridge
Journal:  Pharmacol Ther       Date:  2016-09-05       Impact factor: 12.310

3.  Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.

Authors:  Oksana Sirenko; Evan F Cromwell; Carole Crittenden; Jessica A Wignall; Fred A Wright; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-01       Impact factor: 4.219

4.  Novel MicroRNA Regulators of Atrial Natriuretic Peptide Production.

Authors:  Connie Wu; Pankaj Arora; Obiajulu Agha; Liam A Hurst; Kaitlin Allen; Daniel I Nathan; Dongjian Hu; Pawina Jiramongkolchai; J Gustav Smith; Olle Melander; Sander Trenson; Stefan P Janssens; Ibrahim Domian; Thomas J Wang; Kenneth D Bloch; Emmanuel S Buys; Donald B Bloch; Christopher Newton-Cheh
Journal:  Mol Cell Biol       Date:  2016-06-29       Impact factor: 4.272

Review 5.  Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.

Authors:  Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

6.  Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning.

Authors:  Ahmed E Enayetallah; Dinesh Puppala; Daniel Ziemek; James E Fischer; Sheila Kantesaria; Mathew T Pletcher
Journal:  BMC Pharmacol Toxicol       Date:  2013-09-06       Impact factor: 2.483

7.  Ryanodine Receptor Type 2: A Molecular Target for Dichlorodiphenyltrichloroethane- and Dichlorodiphenyldichloroethylene-Mediated Cardiotoxicity.

Authors:  Kim M Truong; Wei Feng; Isaac N Pessah
Journal:  Toxicol Sci       Date:  2020-11-01       Impact factor: 4.849

Review 8.  Cellular imaging: a key phenotypic screening strategy for predictive toxicology.

Authors:  Jinghai J Xu
Journal:  Front Pharmacol       Date:  2015-09-08       Impact factor: 5.810

9.  Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Yangyang Yu; Shennan Sun; Shifeng Wang; Qiao Zhang; Ming Li; Feng Lan; Shiyou Li; Chunsheng Liu
Journal:  Int J Mol Sci       Date:  2016-01-29       Impact factor: 5.923

Review 10.  Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease Modeling.

Authors:  Daniel R Bayzigitov; Sergey P Medvedev; Elena V Dementyeva; Sevda A Bayramova; Evgeny A Pokushalov; Alexander M Karaskov; Suren M Zakian
Journal:  Cardiol Res Pract       Date:  2016-03-27       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.